By Julianna Zelnhefer, Alex Svanidze, Ryan Leo, and Ava Singer (Boston University); Alvaro Aguilar De Nalda (ESADE); Haci Eren Sidar, Mustafa Arda Sis, Muthu Ramanathan, Josh Lai (University of Nottingham) Photo: Piron Gillaume (Unsplash) Overview of the deal Acquirer:  Boston Scientific Target:  Penumbra Implied Equity Value : $13.4 billion Total Transaction Size:  $14.5 billion Closing Date:  N/A Target Advisor:   Perella Weinberg Partners (financial), Wardwell LL (legal) A